AR Protein in Prostate Cancer Detected with New Imaging Technique

AR Protein in Prostate Cancer Detected with New Imaging Technique
Researchers have developed a new imaging technique that can identify variants of the androgen receptors that do not respond to current androgen-deprivation therapies. The discovery could lead to better clinical management of patients with castration-resistant prostate cancer (CRPC). Findings from the study, “An imaging agent to detect androgen receptor and its active splice variants in prostate cancer,” were published

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *